Skip to main content

Table 2 Factors associated with CD4+ and CD8+ T cells secreting IL-4 and IL-10 in the univariate and multivariate linear regression analysis

From: Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients

Variable

CD4+ T cells IL-4+

CD4+ T cells IL-10+

CD8+ T cells IL-4+

CD8+ T cells IL-10+

 

Univariate

(raw effects)

Multivariate

(adjusted effects)

Univariate

(raw effects)

Multivariate

(adjusted effects)

Univariate

(raw effects)

Multivariate

(adjusted effects)

Univariate

(raw effects)

Multivariate

(adjusted effects)

B (95% CI)

P

Adjusted B (95%CI)

Adjusted P

B (95% CI)

P

Adjusted B (95%CI)

Adjusted P

B (95% CI)

P

Adjusted B (95% CI)

Adjusted P

B (95% CI)

P

Adjusted B (95% CI)

Adjusted P

Age

(≥ 25 vs <  25 years)

0.18(− 0.11,0.48)

0.226

  

− 0.31(− 0.87,0.24)

0.266

  

0.05(− 0.11,0.2)

0.559

  

−0.21(− 0.48,0.05)

0.118

  

Gender

(Male vs Female)

0.22(− 0.03,0.48)

0.087

  

0.02(− 0.47,0.51)

0.935

  

0.02(− 0.11,0.16)

0.723

  

−0.13(− 0.36,0.1)

0.259

  

ALT (<  2 ULN is the reference group)

                

≥ 2 & < 5 ULN

−0.21(−0.52,0.09)

0.171

  

−0.37(− 0.95,0.21)

0.205

  

−0.23(− 0.38,-0.08)

0.004

  

−0.2(− 0.47,0.08)

0.158

  

≥ 5ULN

−0.19(− 0.6,0.22)

0.363

  

−0.27(−1.04,0.49)

0.480

  

−0.29(− 0.49,-0.09)

0.005

  

−0.18(− 0.54,0.19)

0.339

  

Fibroscan

0.06(−0.32,0.43)

0.767

  

−0.2(− 0.91,0.5)

0.570

  

0.04(−0.16,0.23)

0.714

  

−0.14(− 0.47,0.2)

0.426

  

Log HBV DNA

−0.09(− 0.15,-0.02)

0.010

  

−0.1(− 0.23,0.02)

0.094

  

−0.06(− 0.1,-0.03)

0.000

− 0.06(− 0.1,− 0.03)

0.000

-0.03(− 0.09,0.03)

0.315

  

Log HBsAg

− 0.2(− 0.34,-0.06)

0.005

−0.2(− 0.34,-0.06)

0.005

0.87 (0.18,1.56)

0.014

−0.28(− 0.54,-0.03)

0.030

−0.1(− 0.17,-0.03)

0.004

  

−0.09(− 0.22,0.03)

0.153

  

HBeAg(Positive)

−0.32(− 0.58,-0.07)

0.012

  

−0.35(− 0.83,0.13)

0.154

  

−0.19(− 0.31,-0.06)

0.005

  

−0.05(− 0.28,0.19)

0.693

  

HBeAb(Positive)

0.29 (0.03,0.54)

0.026

  

0.28(−0.2,0.76)

0.244

  

0.11(−0.02,0.25)

0.084

  

0.02(−0.21,0.25)

0.884

  

HBsAb(Positive)

0.18(−0.2,0.55)

0.349

  

0.87 (0.18,1.56)

0.014

0.87 (0.19,1.54)

0.013

−0.05(− 0.25,0.14)

0.593

  

0.37 (0.03,0.7)

0.032

0.37 (0.03,0.7)

0.032

Genotype (Genotype C is the reference group)

                

B

−0.18(−0.47,0.11)

0.214

  

0.38(−0.17,0.92)

0.174

  

−0.04(− 0.19,0.11)

0.637

  

0.23(−0.03,0.49)

0.078

  

Other

−0.24(− 0.66,0.18)

0.262

  

0.18(−0.6,0.97)

0.643

  

0(−0.22,0.21)

0.969

  

0.14(−0.23,0.52)

0.450

  

PC mutation (Positive)

0.17(−0.09,0.44)

0.201

  

0.46(−0.03,0.95)

0.068

  

0.1(−0.03,0.24)

0.135

  

0.09(−0.15,0.33)

0.451

  

BCP mutation (Positive)

0.1(−0.17,0.38)

0.455

  

−0.25(− 0.76,0.26)

0.340

  

0.09(− 0.05,0.22)

0.230

  

−0.13(− 0.37,0.11)

0.296

  

PC and BCP mutations (Positive)

0(−0.38,0.37)

0.988

  

−0.16(− 0.87,0.55)

0.655

  

0.2 (0.01,0.39)

0.037

  

−0.03(− 0.37,0.31)

0.857

  
  1. Significant values are shown in boldface. B: Unstandardized Coefficients. HBV genotype: Other included C + D, B + D, B + C, D, and not detected
  2. ALT, alanine aminotransferase; HBeAb, antibody to HBV e antigen; HBeAg, HBV e antigen; HBsAb: antibody to hepatitis B surface antigen; HBsAg, hepatitis B surface antigen; PC: precore; BCP: basal core promoter